Advertisement
ContextVision signs partnership agreement with the University of Washington

“We are thrilled to announce this strategic partnership with a top-tier medical school in clinical and radiological research. This is a critical step toward our vision of developing multiple products within data quality and liver disease management,” says Gerald Pötzsch, CEO of ContextVision.
At the end of 2023, ContextVision launched a strategic venture into data quality, expanding beyond its established business focus on image quality. The new business initiative aims to pioneer AI-based solutions capable of interpreting organ-specific imaging data to enable physiological quantification biomarkers.
The partnership seeks to provide more accurate, and earlier, detection of MASLD using ultrasound, potentially transforming patient outcomes compared to current diagnostic methods.
The UW Medicine healthcare system cares for a large volume of patients with MASLD. This patient volume allows for a comprehensive overview of disease progression, from early to advanced stages, enhancing the quality of radiological datasets.
The collaboration will focus on gathering extensive clinical, ultrasound, and magnetic resonance imaging datasets, tracking disease progression with a rich digital repository of advanced physiological insights for new product development.
Updated: February 5, 2025, 01:54 pm
Published: February 3, 2025
Advertisement